JPS60142979A - １，５‐ベンゾオキサチエピン誘導体 - Google Patents

１，５‐ベンゾオキサチエピン誘導体

Info

Publication number
JPS60142979A
JPS60142979A JP59264106A JP26410684A JPS60142979A JP S60142979 A JPS60142979 A JP S60142979A JP 59264106 A JP59264106 A JP 59264106A JP 26410684 A JP26410684 A JP 26410684A JP S60142979 A JPS60142979 A JP S60142979A
Authority
JP
Japan
Prior art keywords
compound
compound according
methyl
reaction
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59264106A
Other languages
English (en)
Japanese (ja)
Other versions
JPH043397B2 (enExample
Inventor
Hirosada Sugihara
杉原　弘貞
Minoru Hirata
稔 平田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of JPS60142979A publication Critical patent/JPS60142979A/ja
Publication of JPH043397B2 publication Critical patent/JPH043397B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP59264106A 1983-12-14 1984-12-13 １，５‐ベンゾオキサチエピン誘導体 Granted JPS60142979A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/JP1983/000436 WO1985002617A1 (fr) 1983-12-14 1983-12-14 Derives de 1,5-benzoxathiepine et leur procede de preparation
MC83/436 1983-12-14
MC84/168 1984-04-04
MC84/526 1984-11-01

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP1032375A Division JPH02191271A (ja) 1983-12-14 1989-02-10 １，５―ベンゾオキサチエピン誘導体
JP1032376A Division JPH02191272A (ja) 1983-12-14 1989-02-10 １，５―ベンゾオキサチエピン誘導体

Publications (2)

Publication Number Publication Date
JPS60142979A true JPS60142979A (ja) 1985-07-29
JPH043397B2 JPH043397B2 (enExample) 1992-01-23

Family

ID=13790100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59264106A Granted JPS60142979A (ja) 1983-12-14 1984-12-13 １，５‐ベンゾオキサチエピン誘導体

Country Status (4)

Country Link
JP (1) JPS60142979A (enExample)
SU (1) SU1438611A3 (enExample)
WO (1) WO1985002617A1 (enExample)
ZA (1) ZA849718B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62142173A (ja) * 1985-12-10 1987-06-25 Takeda Chem Ind Ltd １，５−ベンゾオキサチエピン誘導体

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2908132B1 (fr) * 2006-11-08 2008-12-19 Pierre Fabre Medicament Sa Procede de synthese du n-[3-[(2-methoxyphenyl)sulfanyl]-2- methylpropyl]-3,4-dihydro-2h-1,5-benzoxathiepin-3-amine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154082C (da) * 1977-11-05 1989-02-27 Pfizer Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62142173A (ja) * 1985-12-10 1987-06-25 Takeda Chem Ind Ltd １，５−ベンゾオキサチエピン誘導体

Also Published As

Publication number Publication date
SU1438611A3 (ru) 1988-11-15
WO1985002617A1 (fr) 1985-06-20
JPH043397B2 (enExample) 1992-01-23
ZA849718B (en) 1986-08-27

Similar Documents

Publication Publication Date Title
KR102744343B1 (ko) 티에노피리미딘디온 acc 억제제의 고체 형태 및 그의 제조 방법
JP2023524493A (ja) ヘテロ環ｇｌｐ－１アゴニスト
TW200836735A (en) Macrocyclic factor VIIA inhibitors useful as anticoagulants
JPS63201196A (ja) アデノシン５’−カルボキサミド誘導体及びその製造方法
JPS61246184A (ja) ジアンヒドロヘキシツト誘導体、その製造方法およびその医薬としての用途
FR2698873A1 (fr) Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
JPS6040428B2 (ja) 新規３−アリ−ル−２−オキサゾリジノン誘導体、その製法及び該誘導体を含有する抗抑うつ剤
Sunkel et al. Synthesis, platelet aggregation inhibitory activity, and in vivo antithrombotic activity of new 1, 4-dihydropyridines
JPS5965089A (ja) ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
FI68623C (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva halogenvincamonderivat
JPS60142979A (ja) １，５‐ベンゾオキサチエピン誘導体
DE69516257T2 (de) 1,4-Benzoxazinderivate, es enthaltende pharmazeutische Zusammensetzung und seine Verwendung
JPH0586067A (ja) 光学活性なチエノトリアゾロジアゼピン化合物
JPH045673B2 (enExample)
JPH0129190B2 (enExample)
FR2539990A1 (fr) Composition pharmaceutique a action psychotrope dopaminergique contenant une 2-piperazinopyrimidine
JPH06505017A (ja) 三環式イソインドリノンの抗ウイルス医薬としての使用、ならびに新規な光学活性イソインドリノン
JPH08502269A (ja) 新規ベンゾピラノン、それらの製造方法およびそれらの使用
US3555019A (en) (2h)-1,4-oxazine derivatives
KR102791326B1 (ko) 피페론구민계 화합물을 유효성분으로 포함하는 혈관질환 예방 또는 치료용 약학적 조성물
WO1998013357A1 (en) Benzo[1,4]thiazine derivatives and drugs comprising the same
JPH01156982A (ja) チエノトリアゾロジアゼピン誘導体
JPH0977753A (ja) １，４−ベンズオキサジン誘導体およびそれからなる医薬
JPH0764840B2 (ja) 縮合ヘテロ７員環化合物
JPH04270222A (ja) 脳機能改善剤